Abnormal Activations of Super-Enhancers Enhance the Carcinogenicity in Lung Adenocarcinoma
Jianlong Zhou,1,2,* Dingxue Wang,3,* Dongxin Tang,3 Wenhua Huang1 1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, People’s Republic of China; 2Department of Oncology, The Affiliated Xinhui Hospital, Southern Medical University, Xinhui, People’s...
Main Authors: | Zhou J, Wang D, Tang D, Huang W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/abnormal-activations-of-super-enhancers-enhance-the-carcinogenicity-in-peer-reviewed-article-CMAR |
Similar Items
-
Identification of Prognostic Factors Related to Super Enhancer-Regulated ceRNA Network in Metastatic Lung Adenocarcinoma
by: Li M, et al.
Published: (2021-10-01) -
Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer
by: Zhiyuan Yao, et al.
Published: (2024-04-01) -
Typical Enhancers, Super-Enhancers, and Cancers
by: Marianna A. Koutsi, et al.
Published: (2022-09-01) -
Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway
by: Te Zhang, et al.
Published: (2022-08-01) -
Super-enhancers complexes zoom in transcription in cancer
by: MengTing Wang, et al.
Published: (2023-07-01)